NASDAQ
Chimeric Therapeutics Limited (CHMMF) has a free cash flow growth of 17.01% as of Friday, May 29, 2026. This represents a 229.97% increase compared to its 12-month average of -13.09%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.